Serratus Intercostal Plane Block Versus Port Infiltration in Laparoscopic Cholecystectomy
NCT ID: NCT07193472
Last Updated: 2025-10-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
128 participants
INTERVENTIONAL
2025-06-02
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
OBJECTIVE The prospective randomised study has the working hypothesis is based on evaluating whether serratus-intercostal block (modified BRILMA) is equal or superior to laparoscopic port infiltration (PI) in terms of quality of postoperative recovery and pain control.
Secondary objectives of the study will be to assess the absence of adverse effects.
MATERIAL AND METHODS the investigators present a low-intervention clinical trial. The sample will be composed of 128 patients divided into two groups according to the analgesic technique (serratus-intercostal and port infiltration), following a 1:1 randomisation, consecutively until the sample size is reached and fulfilling the following criteria: signature of informed consent, over 18 years of age, ASA I-III, undergoing laparoscopic cholecystectomy.
Intraoperatively, patients will receive standard monitoring and induction. Analgesia will consist of a multimodal strategy (8 mg dexamethasone, 1 g paracetamol and 50 mg dexketoprofen pre-incisionally, intraoperative fentanyl on demand and the corresponding regional technique).
In the postoperative period, the main variable to be evaluated in forms designed for this purpose will be the difference in pain assessed by means of an numeric rating scale (NRS scale) and the quality of recovery will be measured by means of the modified Postoperative Quality of Recovery Score (QoR-15 ) recovery scale (15 responses).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Subcostal Transversus Abdominis Block Versus Erector Spinae Block in Open Cholecystectomy
NCT06410911
External Oblique Plane Block and Subcostal Tap Block for Laparoscopic Cholecystectomy
NCT07061262
Bilateral External Oblique Intercostal Plane Block in Laparoscopic Cholecystectomy
NCT06541613
The Efficacy of Thoracoabdominal Nerve Block With Serratus Intercostal Plane and Rectus Sheath Block in Cholecystectomy
NCT06241794
Comparison of Ultrasound-Guided Quadratus Lumborum Plane Block Versus Intraperitoneal and Periportal Bupivacaine Infiltration in Postoperative Analgesia After Laparoscopic Cholecystectomy
NCT06721039
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Postoperative pain remains a significant concern following laparoscopic cholecystectomy (LC), with most patients experiencing moderate to severe pain within the first 24 hours. Traditionally, port-site infiltration (PI) with local anesthetics is employed for analgesia. However, the serratus-intercostal plane block (SIPB), also known as the modified BRILMA block, has demonstrated efficacy in pain management for open cholecystectomy. Its role in LC remains to be clarified.
Objective
The primary objective of this prospective randomised study is to evaluate whether SIPB (modified BRILMA block) provides equivalent or superior postoperative analgesia and quality of recovery compared to port-site infiltration in patients undergoing LC.
Secondary objective: To assess the incidence of adverse effects related to each analgesic technique.
Methods
This study is designed as a low-intervention, prospective, randomized clinical trial. A total of 128 adult patients (ASA I-III) scheduled for elective laparoscopic cholecystectomy will be randomly allocated (1:1) to receive either serratus-intercostal plane block or laparoscopic port infiltration for perioperative analgesia. Randomization will be performed consecutively until the target sample size is reached.
Inclusion Criteria:
Age ≥ 18 years
ASA physical status I-III
Informed consent provided
Exclusion Criteria:
(Coagulopaty, allergy to local anaesthetic, history of chronic pain)
Intraoperative Management:
All patients will receive standardized general anesthesia and multimodal analgesia comprising:
8 mg dexamethasone
1 g paracetamol
50 mg dexketoprofen (administered pre-incisionally)
Fentanyl as needed during surgery
Assigned regional analgesic technique (SIPB or PI)
Postoperative Evaluation:
Primary Outcome Measures:
Pain intensity using the Numerical Rating Scale (NRS) at predefined intervals
Quality of recovery assessed via the modified QoR-15 questionnaire
Secondary Outcome Measure:Incidence of adverse events or complications related to the analgesic techniques
SIPB group: receive The Serratus intercostal plane block as analgesic technique after induction. With the patient lying in supine position, the local anaesthetic is administered in the plane under Serratus muscle at the 8th rib level Infiltration group: in this group the surgeons administered local anaesthetic after inserting the trocar.
Conclusion (anticipated)
This trial aims to determine whether SIPB offers superior analgesic efficacy and recovery quality compared to standard port infiltration in LC, potentially informing improved postoperative pain protocols.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SEQUENTIAL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
port infiltration
patients receiving port infiltration as analgesia
serratus intercostal plane block as analgesic technique
the SIPB will be applied after starting surgery and before general anaesthesia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
serratus intercostal plane block as analgesic technique
the SIPB will be applied after starting surgery and before general anaesthesia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* laparoscopic cholecystectomy
Exclusion Criteria
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital del Rio Hortega
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
María Teresa Fernandez
MD, principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maria Teresa Fernandez, MD
Role: PRINCIPAL_INVESTIGATOR
Hospital del Rio Hortega
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fernandez
Valladolid, Valladolid, Spain
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI-25- 298-H
Identifier Type: OTHER
Identifier Source: secondary_id
PI-25- 298-H
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.